Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder; Drug: GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Chest Pain; Coronary Occlusion; Coronary Artery Disease
Intervention:
Sponsor: William Beaumont Hospitals
Recruiting - verified March 2010